1
|
Cervantes CE, Atta MG. Updates on HIV and Kidney Disease. Curr HIV/AIDS Rep 2023; 20:100-110. [PMID: 36695948 DOI: 10.1007/s11904-023-00645-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/17/2022] [Indexed: 01/26/2023]
Abstract
PURPOSE OF REVIEW With the advent of antiretroviral therapy, HIV infection has become a chronic disease in developed countries. RECENT FINDINGS Non-HIV-driven risk factors for kidney disease, such as APOL1 risk variants and other genetic and environmental factors, have been discovered and are better described. Consequently, the field of HIV-associated kidney disease has evolved with greater attention given to traditional risk factors of CKD and antiretroviral treatment's nephrotoxicity. In this review, we explore risk factors of HIV-associated kidney disease, diagnostic tools, kidney pathology in HIV-positive individuals, and antiretroviral therapy-associated nephrotoxicity.
Collapse
Affiliation(s)
- C Elena Cervantes
- Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 E. Monument Street, Suite 416, Baltimore, MD, 21218, USA
| | - Mohamed G Atta
- Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 E. Monument Street, Suite 416, Baltimore, MD, 21218, USA.
| |
Collapse
|
2
|
Tiulentino Sy-Go JP, Wegehaupt AK, Sethi S, Lieske JC, D’Costa MR. Microsporidium Infection–Associated Acute Kidney Injury in a Patient With HIV. Kidney Med 2022; 4:100390. [PMID: 35072050 PMCID: PMC8767129 DOI: 10.1016/j.xkme.2021.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Patients infected with HIV (human immunodeficiency virus) are at an increased risk of developing acute kidney injury (AKI) compared with patients without HIV infection. We report a rare case of disseminated Microsporidium infection–associated AKI affecting the native kidneys in a 30-year-old Asian woman with HIV infection. She initially presented to an outside institution with AKI after completing treatment with trimethoprim-sulfamethoxazole (Bactrim [Hoffmann-La Roche]) and prednisone for Pneumocystis pneumonia. She was empirically treated with prednisone for presumed acute interstitial nephritis due to Bactrim, and her serum creatinine concentration improved from 3.0 mg/dL to 1.8 mg/dL. She was subsequently initiated on antiretroviral therapy and was also treated with ganciclovir for cytomegalovirus viremia. Because of persistent fever, she was transferred to our institution and was diagnosed with a disseminated Mycobacterium avium complex infection and a disseminated Microsporidium infection. Her serum creatinine concentration increased to 4.2 mg/dL. A kidney biopsy was performed because of her worsening kidney function, which revealed plasma cell–rich acute interstitial nephritis associated with disseminated Microsporidium infection. She was maintained on antiretroviral therapy and was treated with albendazole. This case highlights the fact that there are various etiologies and kidney manifestations of AKI in patients infected with HIV with equally various implications for management; thus, performing a kidney biopsy is often crucial to help elucidate the underlying pathology and guide management.
Collapse
|
3
|
Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression. Cell Death Dis 2021; 12:335. [PMID: 33785732 PMCID: PMC8009943 DOI: 10.1038/s41419-021-03578-y] [Citation(s) in RCA: 44] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Revised: 02/17/2021] [Accepted: 02/19/2021] [Indexed: 02/06/2023]
Abstract
The role of microRNA-21-5p (miR-21-5p) in sepsis-induced acute kidney injury (AKI) has been seldom discussed. Therefore, the objective of this present study was to investigate the mechanism of endothelial progenitor cells-derived exosomes (EPCs-exos) in sepsis-induced AKI via miR-21-5p/runt-related transcription factor 1 (RUNX1) axis. miR-21-5p was downregulated and RUNX1 was upregulated in the kidney of cecal ligation and puncture (CLP) rats, and miR-21-5p targeted RUNX1. Elevation of miR-21-5p improved renal function and renal tissue pathological damage, attenuated serum inflammatory response, as well as reduced apoptosis and oxidative stress response in renal tissues, and regulated endothelial glycocalyx damage marker proteins syndecan-1 and heparanase-1 in CLP rats. Overexpression of RUNX1 abolished the impacts of elevated miR-21-5p in CLP rats. Also, EPCs-exos upregulated miR-21-5p expression, and functioned similar to elevation of miR-21-5p for CLP rats. Downregulating miR-21-5p partially reversed the effects of EPCs-exos on sepsis-induced AKI. Collectively, our study suggests that EPCs release miR-21-5p-containing exosomes to alleviate sepsis-induced AKI through RUNX1 silencing.
Collapse
|
4
|
Elabd H, Rashid T, Elkholi M, Stokes MB. The Case | Acute kidney injury in an African woman with microangiopathic hemolytic anemia and HIV. Kidney Int 2020; 96:253-254. [PMID: 31229043 DOI: 10.1016/j.kint.2019.01.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2019] [Accepted: 01/24/2019] [Indexed: 10/26/2022]
Affiliation(s)
- Hatem Elabd
- Nephrology Division, Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Medicine, University of Cairo, Cairo, Egypt.
| | - Tarek Rashid
- Nephrology Division, Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
| | | | - M Barry Stokes
- Department of Pathology and Cell biology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA
| |
Collapse
|
5
|
Attias P, Moktefi A, Matignon M, Dupuis J, Debiais-Delpech C, Grimbert P, Lang P, Audard V. Monotypic plasma cell interstitial nephritis as the only clinical manifestation in a patient with previously undiagnosed indolent multiple myeloma: A case report. Medicine (Baltimore) 2016; 95:e4391. [PMID: 27495052 PMCID: PMC4979806 DOI: 10.1097/md.0000000000004391] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
INTRODUCTION Predominantly monotypic plasma cell infiltrates are an uncommon renal finding in patients with malignant lymphoplasmacytic proliferation. CASE PRESENTATION We report the case of a 52-year-old man with chronic kidney disease and significant proteinuria associated with a monoclonal immunoglobulin spike (IgGκ). Kidney biopsy revealed the presence of atypical multinucleated CD138 plasma cells with voluminous nuclei stained exclusively with a κ antibody. Electron microscopy showed mesangial and segmental parietal electron-dense, nonorganized hyaline deposits without immunogold labeling for the κ light chain. The bone marrow aspirate revealed 6% of apparently mature plasmocytes without dystrophy. We therefore concluded that the patient had an indolent multiple myeloma with specific renal involvement in the form of malignant monotypic interstitial plasmacytic infiltration. We initiated a specific chemotherapy regimen including bortezomib-cyclophosphamide-dexamethasone. After 4 months of follow-up, creatinine levels had improved slightly and free κ light-chain levels had decreased significantly within the normal range. CONCLUSION This case highlights the need to consider neoplastic interstitial plasma cell infiltration systematically in patients diagnosed with an apparently benign monoclonal gammopathy and to consider adaptation of the chemotherapy regimen, to improve renal function.
Collapse
Affiliation(s)
- Philippe Attias
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Néphrologie et Transplantation, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique, Groupe Hospitalier Henri–Mondor/Albert-Chenevier
| | - Anissa Moktefi
- AP-HP, Département de Pathologie, Groupe Hospitalier Henri-Mondor/Albert-Chenevier
- Université Paris-Est-Créteil (UPEC), Département Hospitalo-Universitaire (DHU) Virus-Immunité-Cancer (VIC), Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, INSERM U 955
| | - Marie Matignon
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Néphrologie et Transplantation, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique, Groupe Hospitalier Henri–Mondor/Albert-Chenevier
- Université Paris-Est-Créteil (UPEC), Département Hospitalo-Universitaire (DHU) Virus-Immunité-Cancer (VIC), Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, INSERM U 955
| | - Jehan Dupuis
- AP-HP, Unité d’Hémopathies Lymphoïdes, Groupe Hospitalier Henri-Mondor/Albert-Chenevier
- UPEC, DHU VIC, IMRB, Equipe 9, INSERM U 955, Créteil
| | - Céline Debiais-Delpech
- Centre de Référence des Amyloses Primitives et des Maladies de Dépôts d’Immunoglobulines Monoclonales
- Département de Pathologie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
| | - Philippe Grimbert
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Néphrologie et Transplantation, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique, Groupe Hospitalier Henri–Mondor/Albert-Chenevier
- Université Paris-Est-Créteil (UPEC), Département Hospitalo-Universitaire (DHU) Virus-Immunité-Cancer (VIC), Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, INSERM U 955
| | - Philippe Lang
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Néphrologie et Transplantation, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique, Groupe Hospitalier Henri–Mondor/Albert-Chenevier
- Université Paris-Est-Créteil (UPEC), Département Hospitalo-Universitaire (DHU) Virus-Immunité-Cancer (VIC), Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, INSERM U 955
| | - Vincent Audard
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Néphrologie et Transplantation, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique, Groupe Hospitalier Henri–Mondor/Albert-Chenevier
- Université Paris-Est-Créteil (UPEC), Département Hospitalo-Universitaire (DHU) Virus-Immunité-Cancer (VIC), Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, INSERM U 955
- Correspondence: Vincent Audard, Service de Néphrologie et Transplantation, Groupe Hospitalier Henri-Mondor/Albert-Chenevier, 51, Avenue du Marechal-de-Lattre-de-Tassigny, 94010 Créteil Cedex, France (e-mail: )
| |
Collapse
|